Search

Search Results

• Comparative Pathomorphology of Lymph Node Changes in Kikuchi-Fujimoto and Autoimmune Diseases with Lymphadenopathy: Own Experience

  Alla Mikhailovna Kovrigina

  80-90

  01.01.2021

• New Technology Capabilities of Direct Antiglobulin Test

  Elena Aleksandrovna Poponina, E.V. Butina, A.V. Iovdii, O.D. Maksimov, G.A. Zaitseva, I.V. Paramonov

  426-429

  01.10.2020

• Treatment of Aggressive Non-Hodgkin’s Lymphomas in Pregnancy

  Yana Konstantinovna Mangasarova, A.U. Magomedova, E.S. Nesterova, L.G. Gorenkova, F.E. Babaeva, R.G. Shmakov, S.K. Kravchenko

  316-321

  01.07.2020

• Long-Term Outcomes of Nivolumab Therapy in Patients with Relapsed/Refractory Classic Hodgkin’s Lymphoma after High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Real Clinical Practice

  Kirill Viktorovich Lepik, N.P. Volkov, N.B. Mikhailova, E.V. Kondakova, L.A. Tsvetkova, Yu.R. Zalyalov, E.E. Lepik, L.V. Fedorova, A.V. Beinarovich, M.V. Demchenkova, O.G. Smykova, P.V. Kotselyabina, I.S. Moiseev, V.V. Baikov, B.V. Afanasyev

  280-288

  01.07.2020

• The Use of Checkpoint Inhibitors in Classical Hodgkin’s Lymphoma during the COVID-19 Pandemic (Pirogov Medical Center’s Experience)

  Vladislav Olegovich Sarzhevskii, E.A. Demina, N.E. Mochkin, A.A. Spornik, A.A. Mamedova, E.G. Smirnova, A.E. Bannikova, A.A. Samoilova, V.S. Bogatyrev, O.Yu. Bronov, Yu.A. Abovich, V.Ya. Melnichenko

  307-315

  01.07.2020

• Safety and Efficacy of BeEAC as a Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphomas

  V.O. Sarzhevskii, Anastasiya Aleksandrovna Samoilova, V.Ya. Melnichenko, Yu.N. Dubinina, N.E. Mochkin, D.S. Kolesnikova, D.A. Fedorenko, E.G. Smirnova, A.E. Bannikova, V.S. Bogatyrev

  185-192

  01.04.2020

• Bendamustine in the Treatment of Relapsed/Refractory Hodgkin’s Lymphoma: Literature Review and Clinical Experience

  Stanislav Sergeevich Shklyaev, N.A. Falaleeva, T.I. Bogatyreva, A.Yu. Terekhova, M.A. Danilova

  136-149

  01.04.2020

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Materials of the 11th International Symposium on Hodgkin Lymphoma (October, 2018; Cologne)

  Elena Andreevna Demina

  350-361

  01.07.2019

• A Clinical and Pathological Comparison of Different Immunomorphological Subvariants of Nodular Lymphocyte-Predominant Hodgkin’s Lymphoma at Initial Diagnosis

  Irina Aleksandrovna Shupletsova, A.M. Kovrigina, T.N. Moiseeva, E.I. Dorokhina, S.M. Kulikov

  185-193

  01.04.2019

• Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma

  S.M. Rastorguev, D.A. Koroleva, E.S. Boulygina, S.V. Tsygankova, N.G. Goncharov, O.S. Naraikin, N.G. Gabeeva, E.E. Zvonkov, A.V. Nedoluzhko

  95-100

  01.01.2019

• Immune Checkpoint Inhibitors in the Treatment of Lymphomas

  Kirill Viktorovich Lepik

  303-312

  01.10.2018

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery

  Nikita Evgen’evich Mochkin, V.O. Sarzhevskii, Yu.N. Dubinina, E.G. Smirnova, D.A. Fedorenko, A.E. Bannikova, D.S. Kolesnikova, V.S. Bogatyrev, N.M. Faddeev, V.Ya. Mel’nichenko

  234-240

  01.07.2018

• Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevitch, E.A. Demina, N.B. Senyuta, I.V. Botezatu, K.V. Smirnova, T.E. Dushen’kina, D.M. Maksimovich, U.V. Paramonova, I.S. Monin, A.V. Lichtenshtein

  160-166

  01.04.2018

• Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma

  M.A. Katin, Ivan Viktorovich Zhil’tsov, V.M. Semenov, D.K. Novik

  182-186

  01.04.2018

• The Use of Brentuximab Vedotin in Relapsed/Refractory Hodgkin’s Lymphoma in the Kransnodar Region

  Ol’ga Dmitrievna Serdyuk, D.A. Yaskul’skii

  50-53

  01.01.2018

• Conventional and Conformal Radiotherapy with and without Beam Intensity Modulation in Patients with Stage II Hodgkin’s Lymphoma with Supradiaphragmal Lesions

  Yu.N. Vinogradova, E.I. Ivanova, A.I. Chumachenko, E.V. Smirnova, G.I. Andreev, A.M. Kalesnik, N.A. Vorob’ev, N.V. Il’in

  70-77

  01.01.2018

• First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov

  443-452

  01.10.2017

• Classification of Conditioning Regimens for Bone Marrow Transplantation: Historical Background and Current Perspectives

  Kapitolina Nikolaevna Melkova, G.D. Petrova, N.V. Gorbunova, T.Z. Chernyavskaya, O.P. Trofimova

  494-500

  01.10.2017

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Prognostic and Differential Diagnostic Value of Standardized Uptake Volume (SUV) of Fluorodeoxyglucose in Patients with Hodgkin’s Lymphoma

  Anatolii Anatol’evich Rukavitsyn, S.I. Kurbanov, O.A. Rukavitsyn

  182-186

  01.04.2017

• Relevance of Positron-Emission Therapy for Optimization of Treatment of Advanced Hodgkin’s Lymphoma Using Intensive ЕАСОРР-14 Program

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, E.G. Medvedovskaya, O.P. Trofimova, V.M. Sotnikov, V.B. Larionova, E.V. Paramonova, L.V. Manzyuk, N.V. Kokosadze, O.V. Mukhortova, I.P. Aslanidi, A.Yu. Zaitseva, L.A. Radkevich, M.S. Rudas, V.A. Manukova, E.A. Osmanov

  150-157

  01.04.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma

  Gayane Sergeevna Tumyan, I.Z. Zavodnova, M.Yu. Kichigina, E.G. Medvedovskaya

  13-24

  01.01.2017

• Features of Imaging of Different Types of Hodgkin’s Lymphoma Using Combined Positron Emission and Computed Tomography

  Aleksei Sergeevich Subbotin, N.G. Afanas’eva

  61-64

  01.01.2017

• Diagnostic and Prognostic Value of Biochemical Markers of Infectious Complications of High-Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation in Malignant Lymphoproliferative Diseases

  Vladislav Olegovich Sarzhevskii, Yu.N. Dubinina, V.Ya. Mel’nichenko

  113-119

  01.01.2017

• Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

  Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev

  406-412

  01.10.2016

• Non-Hodgkin’s Lymphomas in Children: 25-Year Clinical Experience

  Timur Teimurazovich Valiev, A.V. Popa, A.S. Levashov, E.S. Belyaeva, N.S. Kulichkina, B.V. Kurdyukov, R.S. Ravshanova, G.L. Mentkevich

  420-437

  01.10.2016

• Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

  Elena Andreevna Demina

  398-405

  01.10.2016

• Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with Malignant Lymphoproliferative Disorders

  Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, V.Ya. Mel’nichenko

  465-473

  01.10.2016

• Epstein-Barr Virus and Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevich

  101-114

  01.04.2016

• Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

  N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa

  13-21

  01.01.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Treatment of Advanced Stage Hodgkin’s Lymphoma: Literature Review

  Anna Aleksandrovna Leont’eva, E.A. Demina

  255-266

  01.07.2015

• Efficacy and Toxicity of Therapy for Patients with Intermediate-Risk Hodgkin’s Lymphoma: Results of Multicenter Randomized Study

  I.A. Kryachok, Alim Anvarovich Amdiev, I.B. Titorenko, E.M. Aleksik, E.O. Ul’yanchenko, O.I. Novosad, E.S. Filonenko, M.I. Kasich, M.Ya. Kiseleva

  281-286

  01.07.2015

• Autologous Stem Cell Transplantation in Primary Refractory Hodgkin’s Lymphoma: Supposed Zugzwang or Zwischenzug?

  Galina Dmitrievna Petrova, K.N. Melkova, T.Z. Chernyavskaya, N.V. Gorbunova, B.V. Afanas’ev, E.A. Demina, V.N. Kostrykina, V.A. Doronin

  321-330

  01.07.2015

• Modern Aspects of Diagnosis and Treatment of Complicated Forms of Non-Hodgkin’s Lymphomas of Small and Large Intestine

  Ol’ga Aleksandrovna Malikhova, A.O. Tumanyan, V.A. Shalenkov, A.G. Malikhov, Yu.P. Kuvshinov, G.V. Ungiadze

  129-135

  01.04.2015

• Endoscopic and Endosonographic Criteria of Ulcerative Forms of Gastric Non-Hodgkin’s Lymphoma

  Ol’ga Aleksandrovna Malikhova, I.V. Poddubnaya, A.O. Tumanyan, Yu.P. Kuvshinov, G.V. Ungiadze

  54–61

  01.01.2015

• Single-Photon Emission Computed Tomography Synchronized with ECG as Method for Evaluation of Cardiotoxicity of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation for Malignant Lymphoproliferative Disorders

  Vladislav Olegovich Sarzhevskii, D.S. Kolesnikova, M.N. Vakhromeeva, V.Ya. Mel’nichenko

  84–90

  01.01.2015